Cytomegalovirus serologic status and postoperative infection correlated with risk of developing chronic rejection after pulmonary transplantation

Transplantation

Volumn 51, Issue 2, 1991, Pages 433-438

  Keenan, Robert J ^a   Lega, Mark E ^a   Dummer, J Stephen ^a   Paradis, Irvin L ^a   Dauber, James H ^a   Rabinowich, H ^a   Yousem, Samuel A ^a   Hardesty, Robert L ^a   Griffith, Bartley P ^a   Duquesnoy, Rene J ^a   Zeevi, Adriana ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHIOLITIS; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOMEGALOVIRUS INFECTION; GRAFT REJECTION; HEART LUNG TRANSPLANTATION; HEART TRANSPLANTATION; HUMAN; PRIORITY JOURNAL;

ANTIBODIES, VIRAL; BRONCHIOLITIS OBLITERANS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMAN; LUNG TRANSPLANTATION; RISK FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025963850     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199102000-00032     Document Type: Article

References (31)

1. Griffith BP, Paradis IL, Zeevi A, et al. Immunologically mediated disease of the airways after pulmonary transplantation. Ann Surg 1988; 208: 371.
2. Burke CM, Glanville AR, Theodore J, et al. Lung immunogenicity, rejection and obliterative bronchiolitis. Chest 1987; 92: 547.
3. Zeevi A, Fung JJ, Paradis IL, et al. Lymphocytes of bronchoalveolar lavages from heart-lung transplant recipients. J Heart Transplant 1985; 4: 417.
4. Burke CM, Theodore J, Dawkins KD, et al. Post-transplant obli terative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 1984; 86: 824.
5. Milne JEH. Nitrogen dioxide inhalation and bronchiolitis obliterans. J Occup Med 1980; 11: 538.
6. Fortoul TI, Canovalle F, Oliva E, Barrios R. Follicular bronchiolitis in association with connective tissue diseases. Lung 1985; 163: 305.
7. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA. Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985; 312: 152.
8. Wenman WM, Pagtakhan RD, Reed MH, Cherniak V, Albritton W. Adenovirus bronchiolitis in Manitoba: epidemiologic, clinical and radiologic features. Chest 1982; 81: 605.
9. O’Reilly JF. Adult bronchiolitis and parainfluenza type 2. Postgrad Med J 1980; 56: 787.
10. Duncan AJ, Dummer JS, Paradis IL, et al. Cytomegalovirus infection and survival following pulmonary transplantation. J Heart Transplant (in press).
11. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
12. Von Willebrand E, Pettersson E, Ahonen J, Hayry P. CMV infection, class II antigen expression and human kidney allograft rejection. Transplantation 1986; 45: 394.
13. Van Es A, Valdwin WM, Oljan PJ, Tanke HJ, Ploem JS, Van Es LA. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft-rejection episodes and cytomegalovirus infection. Transplantation 1984; 37: 65.
14. Paradis I, Dummer JS, Dauber J, Hardesty R, Griffith B. Risk factors for the development of chronic rejection in the lung allograft. J Heart Transplant 1989; 8: 93.
15. Burke CM, Glanville AR, Macoviak JA, et al. The spectrum of cytomegalovirus infection following human heart-lung transplantation. J Heart Transplant 1986; 5: 267.
16. Fradet G, Scott JP, Sharpies L, et al. Five years experience with heart-lung transplantation: analysis of risk factors of rejection. J Heart Transplant 1990; 9: 82.
17. Yousem SA, Paradis IL, Dauber JH, Griffith BP. Efficacy of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans in heart-lung transplant recipients. Transplantation 1990; 47: 893.
18. Yousem SA, Burke CM, Billingham ME. Pathologic pulmonary alterations in long-term human heart-lung transplantation. Hum Pathol 1985; 16: 911.
19. Rabinowich H, Zeevi A, Paradis IL, et al. Proliferative responses of bronchoalveolar lavage lymphocytes from heart-lung transplant patients. Transplantation 1990; 49: 115.
20. Rubin RH, Tolkoff-Rubin NE, Oliver D, et al. Multicenter seroe- pidemiologic study of the impact of cytomegalovirus infection on renal transplantation. Transplantation 1985; 40: 243.
21. Scott JP, Higenbottam TW, Clellan C, et al. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Transplant Proc 1989; 21: 2592.
22. King TE. Bronchiolitis obliterans. Lung 1989; 167: 69.
23. Allen MD, Burke CM, McGregor CGA, Baldwin JC, Jamieson SW, Theodore J. Steroid-responsive bronchiolitis after human heart- lung transplantation. J Thorac Cardiovasc Surg 1986; 92: 449.
24. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Intern Med 1987; 107: 300.
25. Rubins RH. The indirect effects of cytomegalovirus infection on the outcome of organ transplantation. JAMA 1989; 261: 3607.
26. Skoskiewicz MJ, Colvin RB, Schneeberger EE, Russell PS. Wide spread and selective induction of major histocompatibility complex-determined antigens in vivo by gamma interferon. J Exp Med 1985; 162:1645.
27. Groenewegan G, Buurman WA, Van Der Linden CJ. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature 1985; 316: 361.
28. Yousem SA, Curley JM, Dauber JH, et al. HLA-class II antigen expression in human heart-lung allografts. Transplantation 1990; 49: 991.
29. Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity with HAL-DR beta chain: a means for graft rejection and immunosuppression. J Virol 1988; 62: 100.
30. Beck S, Barrell BG. Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 1988; 331: 209.
31. O’Grady JG, Sutherland S, Harvey F, et al. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in the pathogenesis of vanishing bileduct syndrome after liver transplantation. Lancet 1988; 2: 302